SCHEMBL7365464

SCHEMBL7365464

CNC(=O)C(=O)CCCCCCNC(=O)c1cccc(Oc2ccccc2)c1

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.73
HDAC2 Q92769 5/20 0.73
LMNA P02545 2/20 0.52
HDAC8 Q9BY41 4/20 0.50
HDAC3 O15379 5/20 0.49
NAMPT P43490 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HDAC4 P56524 3/20 0.48
HDAC7 Q8WUI4 3/20 0.48
HDAC10 Q969S8 3/20 0.48
HDAC11 Q96DB2 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
HDAC9 Q9UKV0 3/20 0.48
HDAC5 Q9UQL6 3/20 0.48
NPC1 O15118 1/20 0.48
ERCC5 P28715 1/20 0.47
FEN1 P39748 1/20 0.47
NAAA Q02083 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7396478 0.90 HDAC1 (0.64) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL7371325 0.85 HDAC1 (0.79) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL7375608 0.85 HDAC1 (1.00) HDAC1HDAC2LMNAHDAC8HDAC3
SCHEMBL7372586 0.82 HDAC1 (0.76) HDAC1HDAC2LMNAHDAC8HDAC3
SCHEMBL7372623 0.82 HDAC1 (0.74) HDAC1HDAC2LMNAHDAC3NAMPT
SCHEMBL7373043 0.81 HDAC1 (0.72) HDAC1HDAC2LMNAHDAC8HDAC3
SCHEMBL7364295 0.81 HDAC1 (0.69) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL7368674 0.78 HDAC1 (0.80) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL7373364 0.78 HDAC1 (0.60) HDAC1HDAC2LMNAHDAC8HDAC3
SCHEMBL8782718 0.78 MEN1 (0.57) LMNAHDAC8MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC1 1/4885HDAC2 4/4885LMNA 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.